Skip to main content
Kimberly Heckert, MD, Physical Medicine/Rehab, Philadelphia, PA, Thomas Jefferson University Hospital

KimberlyGail DicuccioHeckertMD

Physical Medicine/Rehab • Philadelphia, PA

Neurorehabilitation, Spinal Cord Injury Medicine

Physician

Join to view full profile

Dr. Heckert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Heckert's full profile

Already have an account?

Education & Training

  • University of Medicine and Dentistry of New Jersey
    University of Medicine and Dentistry of New JerseyStroke & Brain Injury Rehabilitation, 2007 - 2008
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Physical Medicine and Rehabilitation, 2004 - 2007
  • UPMC Medical Education (Mercy)
    UPMC Medical Education (Mercy)Internship, Transitional Year, 2003 - 2004
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2006 - 2025
  • PA State Medical License
    PA State Medical License 2003 - 2024
  • NY State Medical License
    NY State Medical License 2008 - 2010
  • American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
  • American Board of Physical Medicine and Rehabilitation Brain Injury Medicine

Publications & Presentations

PubMed

Press Mentions

  • JAMA Dermatology Publishes Data Showing RINVOQ® (Upadacitinib) Achieved Superiority Versus DUPIXENT® (Dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis
    JAMA Dermatology Publishes Data Showing RINVOQ® (Upadacitinib) Achieved Superiority Versus DUPIXENT® (Dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic DermatitisAugust 4th, 2021
  • Botox Approved to Treat Spasticity in 8 New Arm, Hand Muscles
    Botox Approved to Treat Spasticity in 8 New Arm, Hand MusclesAugust 2nd, 2021
  • AbbVie (ABBV) Announces FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
    AbbVie (ABBV) Announces FDA Approves Expanded BOTOX Label to Include Eight New Muscles to Treat Adults with Upper Limb SpasticityJuly 29th, 2021

Hospital Affiliations

Dr. Kimberly Heckert, Dr. Kimberly Heckert, MD, Dr. K Heckert, Dr. Kimberly Gail Dicuccio Heckert